NgoSeptemba ka-2020, i-Innovita (Tangshan) Biotechnology Co., Ltd.(INNOVITA) yanconywa njengeqela eliphambili kumlo wesizwe wokulwa ubhubhane we-Covid-19.Le kuphela kwenkampani yokuxilongwa kwe-In-vitro kwiPhondo laseHebei efumana eli wonga.
“Emva kokuqhambuka kobhubhani we-Covid-19, i-Innovita (Tangshan) Biotechnology Co., Ltd. yakhawuleza yathatha ithuba lokufumana uncedo lobuchwephesha lokujolisa kwiikiti zoxilongo lwezifo ezosulelayo zokuphefumla iminyaka emininzi, kwaye bathumele ngokukhawuleza abaphezulu ukuba baqhube. uphando lwezenzululwazi.”U-INNOVITA waziswa.
U-INNOVITA uneqela lophando lwenzululwazi elenziwe ziiPhD kunye nabasebenzi abaqeqeshiweyo abaphezulu.Onke amalungu eqela le-R&D azincamile iiholide zawo abuyela kwiziko le-R&D lenkampani esuka kwiindawo ngeendawo, abuyela emsebenzini ngokukhawuleza, kwaye azinikele kuphando nophuhliso lwezixhobo zokufumanisa i-Covid-19.Umdyarho ngokuchasene nexesha, ugqatso ngokuchasene nentsholongwane esasazeka ngokukhawuleza, ukuxhomekeka kuncedo lobuchwephesha bezixhobo zokuphefumla zokuxilonga, ukubeka emngciphekweni wokosulelwa yintsholongwane, kunye nokoyisa ubunzima ukusuka ekuhlolweni kwezinto ezikrwada kunye nokuphuculwa kwenkqubo, ukuya kuqinisekiso lweklinikhi, i-INNOVITA iphuhlise ngempumelelo i-2019-nCoV Antibody. Ikhithi yoVavanyo.
Ngomhla we-9 kaFebruwari, i-2020, imveliso yapasa ingcali yokhuselo loLawulo lweSizwe lokuTya kunye noLawulo lweZiyobisi.Ngomhla we-11 kaFebruwari, ichongiwe njengeprojekthi yophando ephambili yelizwe nguMphathiswa wezeNzululwazi kunye neTeknoloji.Nge-22 kaFebruwari, i-INNOVITA yavelisa uhlobo olutsha lwe-2019-nCoV yekiti yovavanyo lwe-antibody, eyaphuma ngaphandle kwiimveliso ezininzi ezibhengezwe elizweni kwaye yaba yenye yeenkampani ezimbini zokuqala elizweni ukufumana isatifikethi sokubhalisa kuvavanyo lwe-antibody ye-Covid-19. ii-reagents.Iingcali ezidumileyo ziye zaqaphela isiphumo soxilongo lwe-INNOVITA 2019-nCov kit yovavanyo lwe-antibody.
Ngokungafaniyo ne-nucleic acid eyaziwayo yokufumanisa i-reagents ye-Covid-19, i-INNOVITA iphuhlise i-antibody entsha ye-Covid-19 yokufumanisa i-reagent.Kwinkqubo yovavanyo, i-antibody ye-lgM kwisigulana inokufunyanwa, kwaye i-antibody ye-lgM inokubonwa ngomhla we-7 wosulelo lwesigulane okanye ngomhla wesi-3 wokuqalisa, ukubonelela ngereferensi ebanzi yokuxilongwa kweklinikhi.
Ixesha lokuposa: Oct-18-2021